Quantum-Si initiated with a Buy at Alliance Global Partners

Alliance Global Partners initiated coverage of Quantum-Si (QSI) with a Buy rating and $3.75 price target Connecticut-based Quantum-Si develops and markets the Platinum platform of Next Generation Protein Sequencing machines that currently have Research Use Only status without formal indication approval. The “hook” is the potential to be an early leader in the growing field of protein sequencing and the firm’s belief is that the revenue ramp can accelerate and drive scale and profits, though it considers shares speculative as the company is not yet profitable, the analyst tells investors.